SASH1 mRNA and protein levels are also reduced in breast cancer compared to matching normal mammary epithelia [2, 14], with one study suggesting that promoter hypermethylation correlates with repression [14], but the expression and prognostic significance of SASH1 have not yet been investigated in breast tumour cohorts with appreciable clinical annotation or statistical power. This evidence concerns the gene SASH1 and breast cancer.